Debate – Controversies in interstitial lung disease

M. Kreuter (Heidelberg, Germany), K. Antoniou (Heraklion, Greece), C. Ravaglia (Forli, Italy), A. Tzouvelekis (Athens, Greece), D. Culver (Cleveland, United States of America), A. Vorselaars (Nieuwegein, Netherlands)

Source: ERS webinar 2021

Access for REGISTERED non-members

Number: 0

CME test or case report

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany), K. Antoniou (Heraklion, Greece), C. Ravaglia (Forli, Italy), A. Tzouvelekis (Athens, Greece), D. Culver (Cleveland, United States of America), A. Vorselaars (Nieuwegein, Netherlands). Debate – Controversies in interstitial lung disease. ERS webinar 2021

Access for REGISTERED non-members

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012

Interstitial lung disease
Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea
Year: 2015



Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018


Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014



Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


Interstitial lung disease
Source: ERS Course 2015
Year: 2015



Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014


Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019


Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Interstitial lung diseases
Source: ERS Course 2015
Year: 2015

Interstitial lung diseases
Source: Eur Respir Monogr 2015; 70: 99-115
Year: 2015


Interstitial lung diseases
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013


Interstitial lung diseases
Source: Eur Respir Monogr 2014; 65: 79-87
Year: 2014


Interstitial lung diseases
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012